Clinical Trials Browser

Not yet recruiting × Triple Negative Breast Neoplasms × Immune Checkpoint Inhibitors × Clear all

NCT05806385 2025-09-09

LOGIC

Phase 1/2 Not yet recruiting

Triple Negative Breast Neoplasms

NCT06448169 2024-06-07

Observational Study on the Sensitivity of Neoadjuvant Immunotherapy in Early Triple-Negative Breast Cancer

Not yet recruiting

Hypersensitivity, Triple Negative Breast Neoplasms